Form 8-K - Current report:
SEC Accession No. 0001628280-25-021314
Filing Date
2025-05-01
Accepted
2025-05-01 07:02:50
Documents
16
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mdgl-20250501.htm   iXBRL 8-K 27497
2 EX-99.1 exhibit991-1q25earningsrel.htm EX-99.1 45265
6 image_0.jpg GRAPHIC 1132024
7 image_1.jpg GRAPHIC 3074
  Complete submission text file 0001628280-25-021314.txt   1770476

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20250501.xsd EX-101.SCH 1803
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mdgl-20250501_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20250501_pre.xml EX-101.PRE 13060
18 EXTRACTED XBRL INSTANCE DOCUMENT mdgl-20250501_htm.xml XML 2858
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 25899346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)